Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 210875

Expand all

KYNMOBI (APOMORPHINE HYDROCHLORIDE)
10MG
Marketing Status: Prescription
Active Ingredient: APOMORPHINE HYDROCHLORIDE
Proprietary Name: KYNMOBI
Dosage Form; Route of Administration: FILM; SUBLINGUAL
Strength: 10MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N210875
Product Number: 001
Approval Date: May 21, 2020
Applicant Holder Full Name: SUNOVION PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
KYNMOBI (APOMORPHINE HYDROCHLORIDE)
15MG
Marketing Status: Prescription
Active Ingredient: APOMORPHINE HYDROCHLORIDE
Proprietary Name: KYNMOBI
Dosage Form; Route of Administration: FILM; SUBLINGUAL
Strength: 15MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N210875
Product Number: 002
Approval Date: May 21, 2020
Applicant Holder Full Name: SUNOVION PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
KYNMOBI (APOMORPHINE HYDROCHLORIDE)
20MG
Marketing Status: Prescription
Active Ingredient: APOMORPHINE HYDROCHLORIDE
Proprietary Name: KYNMOBI
Dosage Form; Route of Administration: FILM; SUBLINGUAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N210875
Product Number: 003
Approval Date: May 21, 2020
Applicant Holder Full Name: SUNOVION PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
KYNMOBI (APOMORPHINE HYDROCHLORIDE)
25MG
Marketing Status: Prescription
Active Ingredient: APOMORPHINE HYDROCHLORIDE
Proprietary Name: KYNMOBI
Dosage Form; Route of Administration: FILM; SUBLINGUAL
Strength: 25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N210875
Product Number: 004
Approval Date: May 21, 2020
Applicant Holder Full Name: SUNOVION PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
KYNMOBI (APOMORPHINE HYDROCHLORIDE)
30MG
Marketing Status: Prescription
Active Ingredient: APOMORPHINE HYDROCHLORIDE
Proprietary Name: KYNMOBI
Dosage Form; Route of Administration: FILM; SUBLINGUAL
Strength: 30MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N210875
Product Number: 005
Approval Date: May 21, 2020
Applicant Holder Full Name: SUNOVION PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English